Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,899,717
+$1,144,715 QoQ
Shares Held
27,419
+3.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#1,118
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,899,717 | 27,419 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,755,002 | 26,461 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $5,739,897 | 25,121 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $6,127,474 | 26,464 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $5,070,581 | 27,317 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $5,493,195 | 26,218 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $4,522,998 | 25,453 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,408,938 | 22,326 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,629,706 | 21,162 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,722,852 | 20,444 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,575,777 | 23,074 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,282,748 | 22,023 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,479,301 | 18,402 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,133,692 | 19,663 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $4,141,417 | 25,626 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,489,325 | 25,999 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,854,271 | 25,165 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,450,843 | 39,793 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $5,239,709 | 38,698 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $4,129,155 | 38,279 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,290,119 | 38,087 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,042,666 | 37,356 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,042,983 | 37,732 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,294,785 | 37,616 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,950,272 | 40,235 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,305,046 | 43,379 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||